Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2645 | 4 | M-CSF | 465.5 | 32 | |||||||
RA2708 | Tofacitinib | 0.3 | uM | 4 | M-CSF | 369.0 | 33 | ||||
RA2708 | 4 | M-CSF | 274.5 | 34 | |||||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 4 | M-CSF | 356.0 | 54 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 4 | M-CSF | 417.0 | 48 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 4 | M-CSF | 432.5 | 50 | |
N2645 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 4 | M-CSF | 447.0 | 37 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 4 | M-CSF | 380.0 | 43 | |
RA2708 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 4 | M-CSF | 409.0 | 53 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 4 | M-CSF | 476.0 | 37 | |
RA2159 | Poly(I:C) | 2 | ug/mL | 4 | M-CSF | 585.0 | 47 | ||||
N2645 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 4 | M-CSF | 716.0 | 50 | |
N2645 | Poly(I:C) | 2 | ug/mL | 4 | M-CSF | 853.0 | 40 | ||||
RA2708 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 4 | M-CSF | 516.0 | 33 | |
RA2708 | Poly(I:C) | 2 | ug/mL | 4 | M-CSF | 396.0 | 35 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | M-CSF | 453.0 | 51 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | M-CSF | 500.0 | 37 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | M-CSF | 500.5 | 44 | |
N2645 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | M-CSF | 604.0 | 49 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | M-CSF | 446.5 | 50 | |
RA2708 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | M-CSF | 478.0 | 60 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | M-CSF | 707.5 | 52 | |
RA2159 | IL-1 alpha | 100 | ng/mL | 4 | M-CSF | 679.5 | 36 | ||||
N2645 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | M-CSF | 1174.0 | 49 | |
N2645 | IL-1 alpha | 100 | ng/mL | 4 | M-CSF | 992.5 | 42 |